20
Boehringer Ingelheim Pharma Gmbh & Co. Kg Ingelheim Am Rhein De, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Hyoscine butylbromide, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2000-063 - Rev 02
This Chemical Type CEP, issued on May 11, 2018, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 737 associated with this CEP further emphasizes